Table 2.

Mean 6-minute walk distance (6MWD), resting, minimum, and drop in oxygen saturation (SpO2), percentage predicted forced vital capacity (FVC%), and percentage predicted carbon monoxide diffusing capacity (DLCO%) compared by ANOVA between idiopathic pulmonary fibrosis (IPF) and scleroderma (SSc)-interstitial lung disease (ILD) (Table 2A); and between SSc subgroups (Table 2B). All data reported as mean (95% CI).

Table 2A
IPF, n = 46ILD, n = 27p
6MWD, m379 (347–411)349 (308–391)0.27
Resting SpO2, %96 (95–96)97 (97–98)0.003
Minimum SpO2, %87 (86–89)92 (90–94)0.002
Drop in SpO28 (6–9)6 (4–8)0.07
FVC%75 (69–81)64 (57–71)0.02
DLCO%46 (41–52)44 (38–51)0.68
Table 2B
ILD, n = 27PAH, n = 12Neither, n = 13Both, n = 17pTukey Results
6MWD, m349 (302–397)315 (243–387)313 (244–382)312 (251–372)0.7029NA
Resting SpO2, %97 (97–98)97 (97–99)98 (97–99)96 (95–97)*0.2191NA
Minimum SpO2, %92 (89–94)92 (88–95)94 (90–97)87 (84–90)0.0129Both different from ILD and Neither
Drop in SpO2, %6 (3–8)5 (1–8)4 (1–7)9 (7–12)0.0633NA
FVC%64 (58–69)96 (87–106)**91 (83–99)62 (55–69)< 0.0001ILD and Both different from PAH and Neither
DLCO%44 (37–51)***58 (46–70)62 (52–72)37 (28–46)††0.0017Both different from PAH, ILD, and Neither; ILD different from Neither
  • * n = 18;

  • ** n = 10;

  • *** n = 26;

  • n = 9;

  • †† n = 16. SSc-ILD: SSc with interstitial lung disease; SSc-PH: SSc with pulmonary hypertension; SSc-Both: SSc with both ILD and PH; SSc-Neither: SSc with neither ILD nor PH.